Puro Pharmaceuticals: As of the 22nd, the repurchase of shares reached 12.55 million shares, accounting for 1.08%

Puluo Pharmaceuticals announced that on November 18, 2025, the company plans to use 180 million to 360 million yuan of its own funds and loans to repurchase shares through a share repurchase program, for the purpose of equity incentives or employee share ownership plans. The repurchase price will not exceed 23 yuan per share, with a term of 12 months. As of December 22, the company has repurchased 12.55 million shares, accounting for 1.08% of the total share capital, with a highest transaction price of 16.85 yuan per share, a lowest of 15.91 yuan per share, and a total transaction amount of 2.04 billion yuan. The company will continue to repurchase according to the program and fulfill disclosure obligations.